204 related articles for article (PubMed ID: 25463991)
21. Physical activity and survival among men diagnosed with prostate cancer.
Bonn SE; Sjölander A; Lagerros YT; Wiklund F; Stattin P; Holmberg E; Grönberg H; Bälter K
Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):57-64. PubMed ID: 25527697
[TBL] [Abstract][Full Text] [Related]
22. Aspirin and Non-Aspirin NSAID Use and Prostate Cancer Incidence, Mortality, and Case Fatality in the Atherosclerosis Risk in Communities Study.
Hurwitz LM; Joshu CE; Barber JR; Prizment AE; Vitolins MZ; Jones MR; Folsom AR; Han M; Platz EA
Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):563-569. PubMed ID: 30487131
[TBL] [Abstract][Full Text] [Related]
23. Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians' Health Study.
Downer MK; Allard CB; Preston MA; Gaziano JM; Stampfer MJ; Mucci LA; Batista JL
Eur Urol; 2017 Nov; 72(5):821-827. PubMed ID: 28189429
[TBL] [Abstract][Full Text] [Related]
24. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.
Grytli HH; Fagerland MW; Fosså SD; Taskén KA
Eur Urol; 2014 Mar; 65(3):635-41. PubMed ID: 23351721
[TBL] [Abstract][Full Text] [Related]
25. A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence.
Jacobs EJ; Thun MJ; Bain EB; Rodriguez C; Henley SJ; Calle EE
J Natl Cancer Inst; 2007 Apr; 99(8):608-15. PubMed ID: 17440162
[TBL] [Abstract][Full Text] [Related]
26. Association of Aspirin Use With Mortality Risk Among Older Adult Participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Loomans-Kropp HA; Pinsky P; Cao Y; Chan AT; Umar A
JAMA Netw Open; 2019 Dec; 2(12):e1916729. PubMed ID: 31800071
[TBL] [Abstract][Full Text] [Related]
27. Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis.
Huang XZ; Gao P; Sun JX; Song YX; Tsai CC; Liu J; Chen XW; Chen P; Xu HM; Wang ZN
Cancer Causes Control; 2015 Apr; 26(4):589-600. PubMed ID: 25701248
[TBL] [Abstract][Full Text] [Related]
28. Body mass index and weight change in men with prostate cancer: progression and mortality.
Bonn SE; Wiklund F; Sjölander A; Szulkin R; Stattin P; Holmberg E; Grönberg H; Bälter K
Cancer Causes Control; 2014 Aug; 25(8):933-43. PubMed ID: 24810654
[TBL] [Abstract][Full Text] [Related]
29. Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes.
Margel D; Urbach DR; Lipscombe LL; Bell CM; Kulkarni G; Austin PC; Fleshner N
J Clin Oncol; 2013 Sep; 31(25):3069-75. PubMed ID: 23918942
[TBL] [Abstract][Full Text] [Related]
30. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
Jacobs EJ; Rodriguez C; Mondul AM; Connell CJ; Henley SJ; Calle EE; Thun MJ
J Natl Cancer Inst; 2005 Jul; 97(13):975-80. PubMed ID: 15998950
[TBL] [Abstract][Full Text] [Related]
31. Low-dose aspirin and survival in men with prostate cancer: a study using the UK Clinical Practice Research Datalink.
Cardwell CR; Flahavan EM; Hughes CM; Coleman HG; O'Sullivan JM; Powe DG; Murray LJ
Cancer Causes Control; 2014 Jan; 25(1):33-43. PubMed ID: 24310109
[TBL] [Abstract][Full Text] [Related]
32. Aspirin use and mortality from cancer in a prospective cohort study.
Ratnasinghe LD; Graubard BI; Kahle L; Tangrea JA; Taylor PR; Hawk E
Anticancer Res; 2004; 24(5B):3177-84. PubMed ID: 15510608
[TBL] [Abstract][Full Text] [Related]
33. Associations of low-dose aspirin or other NSAID use with prostate cancer risk in the Danish Diet, Cancer and Health Study.
Skriver C; Dehlendorff C; Borre M; Brasso K; Larsen SB; Tjønneland A; Pottegård A; Hallas J; Sørensen HT; Friis S
Cancer Causes Control; 2020 Feb; 31(2):139-151. PubMed ID: 31823168
[TBL] [Abstract][Full Text] [Related]
34. Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancer.
Berglund A; Garmo H; Robinson D; Tishelman C; Holmberg L; Bratt O; Adolfsson J; Stattin P; Lambe M
Eur J Cancer; 2012 Jan; 48(1):75-84. PubMed ID: 21852113
[TBL] [Abstract][Full Text] [Related]
35. Cigarette smoking and prostate cancer-specific mortality following diagnosis in middle-aged men.
Gong Z; Agalliu I; Lin DW; Stanford JL; Kristal AR
Cancer Causes Control; 2008 Feb; 19(1):25-31. PubMed ID: 17906959
[TBL] [Abstract][Full Text] [Related]
36. Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis.
Liu Y; Chen JQ; Xie L; Wang J; Li T; He Y; Gao Y; Qin X; Li S
BMC Med; 2014 Mar; 12():55. PubMed ID: 24678716
[TBL] [Abstract][Full Text] [Related]
37. Advancing age within established Gleason score categories and the risk of prostate cancer-specific mortality (PCSM).
Russo AL; Chen MH; Aizer AA; Hattangadi JA; D'Amico AV
BJU Int; 2012 Oct; 110(7):973-9. PubMed ID: 22954029
[TBL] [Abstract][Full Text] [Related]
38. The impact of the use of aspirin and other nonsteroidal anti-inflammatory drugs on the risk of prostate cancer detection on biopsy.
Bhindi B; Margel D; Hamilton RJ; Fernandes KA; Trottier G; Hersey KM; Finelli A; Trachtenberg J; Zlotta A; Kulkarni GS; Toi A; Evans A; van der Kwast TH; Fleshner NE
Urology; 2014 Nov; 84(5):1073-80. PubMed ID: 25443907
[TBL] [Abstract][Full Text] [Related]
39. Incident cancer risk after the start of aspirin use: results from a Dutch population-based cohort study of low dose aspirin users.
Hollestein LM; van Herk-Sukel MP; Ruiter R; de Vries E; Mathijssen RH; Wiemer EA; Stijnen T; Coebergh JW; Lemmens VE; Herings RM; Stricker BH; Nijsten T
Int J Cancer; 2014 Jul; 135(1):157-65. PubMed ID: 24285345
[TBL] [Abstract][Full Text] [Related]
40. Aspirin and prostate cancer prevention.
Bosetti C; Rosato V; Gallus S; La Vecchia C
Recent Results Cancer Res; 2014; 202():93-100. PubMed ID: 24531782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
